Spots Global Cancer Trial Database for 18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: 18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy
Official Title: 18FluoroDeoxyGlucose-Positron Emission Tomography (PET) in Patients With Melanoma or Non Small Cell Lung Cancer Treated With Immunotherapy
Study ID: NCT03741231
Interventions
Study Description
Brief Summary: Study the EFS and OS according to 18FDG PET in patients with melanoma or non small cell lung cancer treated by immunotherapy.
Detailed Description: Study EFS in patients with melanoma or NSCLC treated by immunotherapy (anti CTLA4 or anti PDL1) and performed18FDG PET Multicentric retrospective study
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHRU de Brest, Brest, , France
CH de LANDERNEAU, Landerneau, , France
Centre Hospitalier de Morlaix, Morlaix, , France
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
